The FDA has approved the manufacturing of a new generic abortion pill, mifepristone, by Evita Solutions. This decision has angered anti-abortion advocates who have been seeking to restrict access to the drug since the overturning of Roe v. Wade. Critics cite a controversial, non-peer-reviewed study claiming high complication rates, while supporters highlight decades of research confirming mifepristone's safety and effectiveness in medication abortions. The FDA stated its limited discretion in approving generic drug applications.
Reviewed by JQJO team
#abortion #fda #rights #medicine #politics
Comments